David Roulois
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 4
- IL-33, ST2, and ILC Pathways 4
- Immune Cell Function and Interaction 3
- Immune cells in cancer 3
- interferon and immune responses 2
-
- Epigenetics and DNA Methylation 4
- Co-authors
- Daniel D. De Carvalho (3 shared papers)Helen Loo Yau (2 shared papers)Rajat Singhania (2 shared papers)Arnavaz Danesh (1 shared paper)Shu Yi Shen (1 shared paper)Han Han (1 shared paper)Peter A. Jones (1 shared paper)Gangning Liang (1 shared paper)
- Journals
- Oncotarget (3 papers)Clinical Cancer Research (1 paper)European Journal of Immunology (1 paper)Blood (1 paper)International Journal of Experimental Pathology (1 paper)
- Partner nations
- FranceUnited KingdomCanada
In The Last Decade
David Roulois
19 papers receiving 1.6k citations
David Roulois's Hit Papers
Peers
Comparison fields: 5 of 73
- Immunology 613
- Oncology 409
- Molecular Biology 858
- Cancer Research 141
- Hematology 102
Countries citing papers authored by David Roulois
This map shows the geographic impact of David Roulois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Roulois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Roulois more than expected).
Fields of papers citing papers by David Roulois
This network shows the impact of papers produced by David Roulois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Roulois. The network helps show where David Roulois may publish in the future.
Co-authors
The 25 scholars most cited alongside David Roulois, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts Hit paper breakdown → | 2015 | 1026 |
| 2 | 2019 | 145 | |
| 3 | 2013 | 100 | |
| 4 | 2019 | 62 | |
| 5 | 2012 | 36 | |
| 6 | 2015 | 33 | |
| 7 | 2012 | 29 | |
| 8 | 2015 | 24 | |
| 9 | 2016 | 23 | |
| 10 | 2022 | 18 | |
| 11 | 2021 | 17 | |
| 12 | 2016 | 15 | |
| 13 | 2011 | 13 | |
| 14 | 2011 | 13 | |
| 15 | 2019 | 11 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2018 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About David Roulois
David Roulois is a scholar working on Immunology, Molecular Biology, Oncology, Epidemiology and Genetics, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (4 papers), IL-33, ST2, and ILC Pathways (4 papers), Epigenetics and DNA Methylation (4 papers), Immune Cell Function and Interaction (3 papers), Immune cells in cancer (3 papers), interferon and immune responses (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Immunology (613 citations), Oncology (409 citations), Molecular Biology (858 citations), Cancer Research (141 citations) and Hematology (102 citations). David Roulois has collaborated with scholars based in France, United Kingdom and Canada. Frequent co-authors include Daniel D. De Carvalho, Helen Loo Yau, Rajat Singhania, Arnavaz Danesh, Shu Yi Shen, Han Han, Peter A. Jones, Gangning Liang, Catherine O′Brien and Trevor J. Pugh. Their work appears in journals such as Oncotarget, Clinical Cancer Research, European Journal of Immunology, Blood and International Journal of Experimental Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.